Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia.
- Resource Type
- Article
- Source
- JADPRO: Journal of the Advanced Practitioner in Oncology; Sep/Oct2014, Vol. 5 Issue 5, p348-354, 7p
- Subject
- Language
- ISSN
- 21500878